A Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne

Completed · Phase 1/Phase 2

Conditions studied: Acne Vulgaris

In brief

This is a 12 week, multi-site, double-blind, vehicle-controlled study in subjects with mild to moderate facial acne. Subjects will be randomized 1:1 to apply either topical NAG or vehicle gel daily. Subjects will be evaluated for clinical acne and quality of life outcomes at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks.

Key facts

Study ID

NCT02404285

Run by

Next Science TM

People needed

68

Starts

2015-03-01

Expected to finish

2015-09-01

Last updated by the study team

2023-11-08

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female ages 12 and above
• Has 10 or more inflammatory lesions on the face (papules and pustules) as determined by qualified examiner at Start of Treatment.
• In the area to be treated, has no significant facial dermatological conditions other than acne (as determined by the investigator) that would interfere with any study treatment or procedure
• Is willing and able to discontinue use of all baseline acne treatments for the duration of their trial participation
• Agrees to refrain from professional facial treatments during their trial participation.
• Agrees to avoid tanning booth use and minimize sun exposure during their trial participation.
• Is willing and able to follow instructions and procedures including attending scheduled study visits, which will require adequate transportation to the study site
• Is able to read, understand and sign the informed consent document and communicate with study staff and investigator. If the subject is a minor, the parent or documented legal guardian must meet these consent requirements and the subject must be able to understand, agree to, and sign the assent form.

You may not qualify if…

• Has more than 2 nodules/cystic acne lesions on the face
• Has a history of significant reactions to topical acne treatments, or a known allergy or hypersensitivity to any listed ingredients
• Has any history of skin malignancy
• Has significant facial hair that would interfere with evaluation of acne lesions or global assessment.
• Has used any systemic medications (including antibiotics, estrogens, retinoids) primarily for treatment of acne in the 21 days prior to randomization.
• Has used estrogens primarily as treatment for acne in the 21 days prior to randomization (estrogens prescribed for other reasons will be allowed if stable for at least 30 days prior to randomization).
• Has had any professional facial treatments in the 14 days prior to randomization.
• Has received any investigational treatment in the 30 days prior to randomization.
• Have any significant medical problems or other issues that would, in the investigator's judgment, affect their suitability for participation in this trial.

Where it is running

• Fleming Island Center for Clinical Research — Jacksonville, Florida, United States
• Jacksonville Center for Clinical Research — Jacksonville, Florida, United States
• St. Johns Center for Clinical Research — Ponte Vedra, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.